These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6734073

  • 1. Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis (CAPD).
    Heaton A, Ward MK, Johnston DG, Nicholson DV, Alberti KG, Kerr DN.
    Clin Sci (Lond); 1984 Jul; 67(1):121-30. PubMed ID: 6734073
    [Abstract] [Full Text] [Related]

  • 2. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
    Smit W, de Waart DR, Struijk DG, Krediet RT.
    Perit Dial Int; 2000 Jul; 20(5):557-65. PubMed ID: 11117247
    [Abstract] [Full Text] [Related]

  • 3. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
    Plum J, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B.
    Perit Dial Int; 1999 Jul; 19(5):418-28. PubMed ID: 11379854
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of glycerol as an osmotic agent for continuous ambulatory peritoneal dialysis in end-stage renal failure.
    Heaton A, Ward MK, Johnston DG, Alberti KG, Kerr DN.
    Clin Sci (Lond); 1986 Jan; 70(1):23-9. PubMed ID: 3510801
    [Abstract] [Full Text] [Related]

  • 5. Effect of alternative osmotic agents on peritoneal transport.
    Waniewski J, Werynski A, Heimbürger O, Park MS, Lindholm B.
    Blood Purif; 1993 Jan; 11(4):248-64. PubMed ID: 8297566
    [Abstract] [Full Text] [Related]

  • 6. Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent?
    Rippe B, Zakaria el-R, Carlsson O.
    Perit Dial Int; 1996 Jan; 16 Suppl 1():S97-103. PubMed ID: 8728172
    [Abstract] [Full Text] [Related]

  • 7. Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle.
    Heaton A, Johnston DG, Burrin JM, Orskov H, Ward MK, Alberti KG, Kerr DN.
    Clin Sci (Lond); 1983 Nov; 65(5):539-45. PubMed ID: 6352157
    [Abstract] [Full Text] [Related]

  • 8. A randomized clinical trial with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution.
    Van Biesen W, Boer W, De Greve B, Dequidt C, Vijt D, Faict D, Lameire N.
    Perit Dial Int; 2004 Nov; 24(3):222-30. PubMed ID: 15185770
    [Abstract] [Full Text] [Related]

  • 9. Peritoneal transport during dialysis with amino acid-based solutions.
    Park MS, Heimbürger O, Bergström J, Waniewski J, Werynski A, Lindholm B.
    Perit Dial Int; 1993 Nov; 13(4):280-8. PubMed ID: 8241328
    [Abstract] [Full Text] [Related]

  • 10. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J, Schoenicke G, Grabensee B.
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [Abstract] [Full Text] [Related]

  • 11. Twenty-four hour hormonal and metabolic profiles in uraemic patients before and during treatment with continuous ambulatory peritoneal dialysis.
    Heaton A, Johnston DG, Haigh JW, Ward MK, Alberti KG, Kerr DN.
    Clin Sci (Lond); 1985 Oct; 69(4):449-57. PubMed ID: 4042546
    [Abstract] [Full Text] [Related]

  • 12. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.
    Mistry CD, Mallick NP, Gokal R.
    Lancet; 1987 Jul 25; 2(8552):178-82. PubMed ID: 2885639
    [Abstract] [Full Text] [Related]

  • 13. Peritoneal transport characteristics with glucose polymer based dialysate.
    Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, Krediet RT.
    Kidney Int; 1996 Sep 25; 50(3):979-86. PubMed ID: 8872974
    [Abstract] [Full Text] [Related]

  • 14. New solutions for peritoneal dialysis in adult and pediatric patients.
    Shockley TR, Martis L, Tranaeus AP.
    Perit Dial Int; 1999 Sep 25; 19 Suppl 2():S429-34. PubMed ID: 10406559
    [Abstract] [Full Text] [Related]

  • 15. [The effect of dialysis solutions containing amino acids on the nutritional status of patients treated with continuous ambulatory peritoneal dialysis].
    Opatrná S, Liska J, Vít L, Hostasová A, Opatrný K.
    Cas Lek Cesk; 1997 Jun 26; 136(13):409-12. PubMed ID: 9333515
    [Abstract] [Full Text] [Related]

  • 16. The influence of automated peritoneal dialysis on the decrease in residual renal function.
    Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F.
    Nephrol Dial Transplant; 1999 May 26; 14(5):1224-8. PubMed ID: 10344365
    [Abstract] [Full Text] [Related]

  • 17. Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis.
    Goodship TH, Lloyd S, McKenzie PW, Earnshaw M, Smeaton I, Bartlett K, Ward MK, Wilkinson R.
    Clin Sci (Lond); 1987 Nov 26; 73(5):471-8. PubMed ID: 3315397
    [Abstract] [Full Text] [Related]

  • 18. The effect of dialysate glucose on phagocyte superoxide generation in CAPD patients.
    Kashem A, Nomoto Y, Tanabe R, Nishina M, Endoh H, Nakajima K, Endoh M, Sakai H, Nakazawa H.
    Perit Dial Int; 1998 Nov 26; 18(1):52-9. PubMed ID: 9527030
    [Abstract] [Full Text] [Related]

  • 19. Ultrafiltration with icodextrins in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.
    Neri L, Viglino G, Cappelletti A, Gandolfo C, Cavalli PL.
    Adv Perit Dial; 2000 Nov 26; 16():174-6. PubMed ID: 11045287
    [Abstract] [Full Text] [Related]

  • 20. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
    Mistry CD, Gokal R, Peers E.
    Kidney Int; 1994 Aug 26; 46(2):496-503. PubMed ID: 7967363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.